MAPT and Alzheimer disease: Elevated p25/p35 ratios have been reported to occur in AD patients (Patrick et al., 1999; Tseng et al., 2002) and increased expression of p25 is linked with aberrant phosphorylation of tau (Noble et al., 2003; Plattner et al., 2006).